Format
Sort by

Send to

Choose Destination

Search results

Items: 12

1.

Harnessing RNAi-based nanomedicines for therapeutic gene silencing in B-cell malignancies.

Weinstein S, Toker IA, Emmanuel R, Ramishetti S, Hazan-Halevy I, Rosenblum D, Goldsmith M, Abraham A, Benjamini O, Bairey O, Raanani P, Nagler A, Lieberman J, Peer D.

Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):E16-22. doi: 10.1073/pnas.1519273113. Epub 2015 Dec 23.

2.

Recurrent inactivating RASA2 mutations in melanoma.

Arafeh R, Qutob N, Emmanuel R, Keren-Paz A, Madore J, Elkahloun A, Wilmott JS, Gartner JJ, Di Pizio A, Winograd-Katz S, Sindiri S, Rotkopf R, Dutton-Regester K, Johansson P, Pritchard AL, Waddell N, Hill VK, Lin JC, Hevroni Y, Rosenberg SA, Khan J, Ben-Dor S, Niv MY, Ulitsky I, Mann GJ, Scolyer RA, Hayward NK, Samuels Y.

Nat Genet. 2015 Dec;47(12):1408-10. doi: 10.1038/ng.3427. Epub 2015 Oct 26.

3.

Identifying the most sensitive and specific sign and symptom combinations for cholera: results from an analysis of laboratory-based surveillance data from Haiti, 2012-2013.

Lucien MA, Schaad N, Steenland MW, Mintz ED, Emmanuel R, Freeman N, Boncy J, Adrien P, Joseph GA, Katz MA.

Am J Trop Med Hyg. 2015 Apr;92(4):758-64. doi: 10.4269/ajtmh.14-0429. Epub 2015 Mar 2.

4.

YAP and the drug resistance highway.

Keren-Paz A, Emmanuel R, Samuels Y.

Nat Genet. 2015 Mar;47(3):193-4. doi: 10.1038/ng.3228.

5.

Isolation and structural elucidation of cytotoxic compounds from the root bark of Diospyros quercina (Baill.) endemic to Madagascar.

Ruphin FP, Baholy R, Emmanuel R, Amelie R, Martin MT, Koto-Te-Nyiwa N.

Asian Pac J Trop Biomed. 2014 Mar;4(3):169-75. doi: 10.1016/S2221-1691(14)60227-6.

6.

A highly recurrent RPS27 5'UTR mutation in melanoma.

Dutton-Regester K, Gartner JJ, Emmanuel R, Qutob N, Davies MA, Gershenwald JE, Robinson W, Robinson S, Rosenberg SA, Scolyer RA, Mann GJ, Thompson JF, Hayward NK, Samuels Y.

Oncotarget. 2014 May 30;5(10):2912-7.

7.

Diversities in presentations of extrapulmonary tuberculosis.

Neelakantan S, Nair PP, Emmanuel RV, Agrawal K.

BMJ Case Rep. 2013 Feb 28;2013. pii: bcr2013008597. doi: 10.1136/bcr-2013-008597.

8.

RNA inhibition highlights cyclin D1 as a potential therapeutic target for mantle cell lymphoma.

Weinstein S, Emmanuel R, Jacobi AM, Abraham A, Behlke MA, Sprague AG, Novobrantseva TI, Nagler A, Peer D.

PLoS One. 2012;7(8):e43343. doi: 10.1371/journal.pone.0043343. Epub 2012 Aug 14.

9.

Ileocolic intussusception due to a cecal endometriosis: case report and review of literature.

Emmanuel R, Léa M, Claude P, Antonio V, Marianne Z, Christophe P, Christophe B.

Diagn Pathol. 2012 Jun 7;7:62. doi: 10.1186/1746-1596-7-62. Review.

10.

'A harmless but confusing tumour on the anterior maxilla'.

Emmanuel RV, Neelakantan S, Nair PP, Thomas S, Saxena V, Yadav NS.

BMJ Case Rep. 2012 May 23;2012. pii: bcr1220115394. doi: 10.1136/bcr.12.2011.5394.

11.

Identification of CTCF as a master regulator of the clustered protocadherin genes.

Golan-Mashiach M, Grunspan M, Emmanuel R, Gibbs-Bar L, Dikstein R, Shapiro E.

Nucleic Acids Res. 2012 Apr;40(8):3378-91. doi: 10.1093/nar/gkr1260. Epub 2011 Dec 30.

12.

Nuclear factor of activated T cells balances angiogenesis activation and inhibition.

Zaichuk TA, Shroff EH, Emmanuel R, Filleur S, Nelius T, Volpert OV.

J Exp Med. 2004 Jun 7;199(11):1513-22.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk